Accessibility Menu
Sonova Ag logo

Sonova Ag(OTC) SONVY

Market Cap$17.18BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+559%
5 Year-19%
1 Year+3%
1 Month+6%
$57.30
-0.93%
-0.53Today
Sonova Ag last closing stock price
MetricPriceDate
Last closeUSD 57.832026-08-28
Sonova Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.93%USD 60.832026-08-21
1 month+6.17%USD 54.472026-07-29
3 month+12.11%USD 51.582026-05-29
Year to date+14.63%USD 50.452025-12-31
1 year+2.94%USD 56.182025-08-28
3 year+15.46%USD 50.092023-08-29
5 year-19.17%USD 71.552021-08-27
Since inception+558.75%USD 8.782008-12-12

Sonova Ag Financials at a Glance

Market Cap

$17.18BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 7.45B

Net Income (TTM)

CHF 1.08B

EPS (TTM)

$1.80

P/E Ratio

32.04

Dividend

$1.16

Beta (Volatility)

0.81 (Low)

Price

$57.30

Volume

4,328

Open

$57.05

Previous Close

$57.83

Daily Range

$56.95 - $57.43

52-Week Range

$42.26 - $61.10

Estimated Earnings Date

Nov 12, 2026

SONVY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sonova Ag

Sonova Holding AG is a leading developer, manufacturer, and global distributor of hearing health solutions catering to all age groups. The company operates primarily in two segments: Hearing Instruments and Cochlear Implants, offering a diverse range of innovative products and services.

Products and Services
  • Advanced hearing aids with wireless communication capabilities
  • Cochlear implants for individuals with severe hearing loss
  • Consumer audio electronics, including high-fidelity headphones and hearables
Growth Outlook
  • Projected revenue growth driven by increasing global demand for hearing solutions
  • Expansion into emerging markets enhances market penetration opportunities
  • Investment in R&D supports innovation and product development
Financial Highlights
  • Recent quarterly revenue of CHF 1.81 billion, reflecting strong market performance
  • Net income margin of 19.75% in the latest quarter indicates robust profitability
  • Trailing twelve months (TTM) dividend yield of 2.03% demonstrates shareholder return commitment
Sonova Holding AG stands out in the healthcare sector, particularly in the medical devices industry, with a strong focus on hearing health. The company’s commitment to innovation is evident in its extensive product offerings, which include advanced hearing aids and cochlear implants. With a significant international presence, Sonova operates in various regions, including the United States, Europe, and Asia Pacific, ensuring a broad market reach. The growth outlook for Sonova is promising, driven by increasing global awareness of hearing health and the rising prevalence of hearing loss. The company’s strategic investments in research and development are expected to yield innovative products, further solidifying its market position. Additionally, expansion into emerging markets presents new opportunities for revenue growth. Financially, Sonova has demonstrated resilience, with a recent quarterly revenue of CHF 1.81 billion, showcasing its ability to capture market demand effectively. The net income margin of 19.75% reflects strong operational efficiency and profitability. Furthermore, the TTM dividend yield of 2.03% highlights the company’s commitment to returning value to shareholders, making it an attractive option for potential investors. Overall, Sonova Holding AG presents a compelling case for investment consideration in the growing healthcare sector.
AI Generated • Aug 31, 2026

Industry

Healthcare Equipment and Supplies

Employees

18,447

CEO

Eric Alain Bernard, MBA

Headquarters

Stäfa, ZH 8712, CH

SONVY Financials

Key Financial Metrics (TTM)

Gross Margin

73.72%

Operating Margin

18.74%

Net Income Margin

14.90%

Return on Equity

21.31%

Return on Capital

15.63%

Return on Assets

9.54%

Earnings Yield

3.12%

Dividend Yield

2.01%

Payout Ratio

48.83%

Stock Overview

Market Cap

$17.18BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

297.02M

Volume

4.33K

Avg. Volume

15.98K

Financials (TTM)

Gross Profit

CHF 5.39B

Operating Income

CHF 1.37B

EBITDA

CHF 1.81B

Operating Cash Flow

CHF 1.48B

Capital Expenditure

-CHF 172.44M

Free Cash Flow

CHF 1.31B

Cash & ST Invst.

CHF 722.10M

Total Debt

CHF 1.71B

Sonova Ag Performance Analysis

Sonova Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CHF 3,913,447,4476.9%
20242024-03-31CHF 4,091,250,6554.5%
20252025-03-31CHF 4,074,745,677-0.4%
20262026-03-31CHF 4,492,499,01710.3%
Sonova Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-2.2%
Q42025-03-3110.9%
Q22025-09-30-12.6%
Q42026-03-312.0%
Sonova Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CHF 2.24-0.4%
20242024-03-31CHF 2.271.1%
20252025-03-31CHF 2.04-10.1%
20262026-03-31CHF 1.80-11.8%
Sonova Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-41.4%
Q42025-03-3159.0%
Q22025-09-30-44.1%
Q42026-03-3191.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

CHF 1.81B

-3.3%

Gross Profit

CHF 1.37B

+0.2%

Gross Margin

75.54%

N/A

Market Cap

$17.18BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$931.15K

N/A

Employees

18,447

N/A

Net Income

CHF 357.98M

+0.5%

EBITDA

CHF 557.08M

+41.9%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

CHF 722.10M

+40.5%

Total Debt

CHF 1.71B

-4.6%

Accounts Receivable

CHF 654.70M

+1.8%

Inventory

CHF 381.00M

-12.5%

Long Term Debt

CHF 1.53B

-11.1%

Short Term Debt

CHF 186.30M

+134.9%

Return on Assets

9.54%

N/A

Return on Invested Capital

15.22%

N/A

Free Cash Flow

CHF 411.35M

-12.2%

Operating Cash Flow

CHF 457.99M

-8.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GIKLYGrifols, S.A.
$5.78+0.52%
SNNUFSmith & Nephew plc
$15.75+1.74%
SBMFFSino Biopharmaceutical Limited
$0.74-1.60%
FMCQFFresenius Medical Care AG
$43.01-16.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.54-0.18%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.95+0.11%
NUNu Holdings
$14.48+0.01%
BITOProShares Trust - ProShares Bitcoin ETF
$10.66+0.02%

Questions About SONVY

What is the current price of Sonova Ag?

Sonova Ag is trading at $57.30 per share.

What is the 52-week range for Sonova Ag?

Over the past 52 weeks, Sonova Ag has traded between $42.26 and $61.10.

How much debt does Sonova Ag have?

As of the most recent reporting period, Sonova Ag reported total debt of CHF 2.13B.

How much cash does Sonova Ag have on hand?

Sonova Ag reported CHF 898.39M in cash and cash equivalents in its most recent financial results.

What is Sonova Ag’s dividend yield?

Sonova Ag currently has a dividend yield of 2.01%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.